1. Body JJ (1992) Pamidronate for tumor-induced hypercalcaemia and tumor induced osteolyses: what is the optimal therapeutic regimen? (abstract). Proc ASCO Meet 11:411
2. Coleman R (1991) Clinical aspects of metastatic bone disease. In: Coleman R, Reubens RD (eds) Metastatic bone disease. Parthenon, Lancs, UK, pp 11?25
3. Delmas PD, Charhon S, Chapuy MC, Vignon E, Brian�on D (1982) Long term effects of dichloromethylene disphosphonate (Cl2 MDP) on skeletal lesons in multiple myeloma. Metab Bone Dis Relat Res 4:163?168
4. Elomaa I, Blomquist C, Porkka L, Lamberg-Allard D, Bergstr�m GH (1987) Treatment of skeletal disease in breast cancer: a controlled clodronate trial. Bone 8 [Suppl 1]:53?56
5. Fleisch H (1991) Bisphosphonates. Pharmacology and use in the treatment of tumor induced hypercalcaemia and metastatic bone disease. Drugs 42:919?944